璋利國際(01693.HK)預計年度虧損約2430萬林吉特
格隆匯5月9日丨璋利國際(01693.HK)公告,集團預計截至2025年3月31日止十二個月期間將錄得公司股東應佔未經審覈虧損淨額約24.3百萬林吉特,而截至2024年3月31日止十二個月期間錄得公司股東應佔虧損淨額1.2百萬林吉特。
報告期間虧損淨額增加主要由於(其中包括)(i)其他收入減少,主要由於相關期間應付商品及服務稅撥回所致;(ii)報告期間金融資產及合約資產減值虧損撥回減少;及(iii)報告期間客戶兌現履約保函及相關開支令報告期間產生的行政及其他開支增加。上述負面影響被報告期間的收益增加部分抵銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.